It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Fully automated machine learning (AutoML) for predictive modeling is becoming a reality, giving rise to a whole new field. We present the basic ideas and principles of Just Add Data Bio (JADBio), an AutoML platform applicable to the low-sample, high-dimensional omics data that arise in translational medicine and bioinformatics applications. In addition to predictive and diagnostic models ready for clinical use, JADBio focuses on knowledge discovery by performing feature selection and identifying the corresponding biosignatures, i.e., minimal-size subsets of biomarkers that are jointly predictive of the outcome or phenotype of interest. It also returns a palette of useful information for interpretation, clinical use of the models, and decision making. JADBio is qualitatively and quantitatively compared against Hyper-Parameter Optimization Machine Learning libraries. Results show that in typical omics dataset analysis, JADBio manages to identify signatures comprising of just a handful of features while maintaining competitive predictive performance and accurate out-of-sample performance estimation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 JADBio Gnosis DA S.A., Science and Technology Park of Crete, Heraklion, Greece (GRID:grid.511969.3); University of Crete, Department of Computer Science, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437); Institute of Applied and Computational Mathematics, Foundation for Research and Technology, Hellas, Heraklion, Greece (GRID:grid.511961.b)
2 JADBio Gnosis DA S.A., Science and Technology Park of Crete, Heraklion, Greece (GRID:grid.511969.3)
3 JADBio Gnosis DA S.A., Science and Technology Park of Crete, Heraklion, Greece (GRID:grid.511969.3); University of Crete, Department of Computer Science, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437)
4 University of Crete, Department of Computer Science, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437)
5 National Institutes of Health, National Cancer Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
6 Chief Executive Officer, Indivumed Group, Hamburg, Germany (GRID:grid.94365.3d)
7 Democritus University of Thrace, Laboratory of Pharmacology, Medical School, Alexandroupolis, Greece (GRID:grid.12284.3d) (ISNI:0000 0001 2170 8022); Hellenic Mediterranean University Research Centre, Institute of Agri-food and Life Sciences, Crete, Greece (GRID:grid.419879.a) (ISNI:0000 0004 0393 8299)
8 JADBio Gnosis DA S.A., Science and Technology Park of Crete, Heraklion, Greece (GRID:grid.511969.3); Ilia State University, Institute of Chemical Biology, Tbilisi, Georgia (GRID:grid.428923.6) (ISNI:0000 0000 9489 2441)